Elisa Rahikkala

2.1k citations
38 papers · 269 indexed · h-index 9
Topics
Genomics and Rare Diseases (9 papers)Genetics and Neurodevelopmental Disorders (7 papers)RNA modifications and cancer (6 papers)

In The Last Decade

Elisa Rahikkala

29 papers receiving 267 citations

Peers

Elisa Rahikkala
Comparison fields: 5 of 58
  • Molecular Biology 163
  • Genetics 81
  • Clinical Biochemistry 61
  • Cellular and Molecular Neuroscience 37
  • Biochemistry 31
Replace Akihiko Miyauchi with:
Akihiko Miyauchi Japan
Heiko Brennenstuhl Germany
Noora Shahbeck Qatar
Malavika Hebbar India
Ayelet Zerem Israel
Anna Marcé‐Grau Spain
Isabel Fineza Portugal
Anthony S. Castanza United States
Tessa van Dijk Netherlands
Rocío Sánchez-Alcudia Spain
Elisa Rahikkala relative to Akihiko Miyauchi Japan Akihiko Miyauchi's profile →
Citations per field
00.5×1.5×
Akihiko Miyauchi · 1×
Citations per year

Countries citing papers authored by Elisa Rahikkala

Since Specialization
Citations

This map shows the geographic impact of Elisa Rahikkala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Rahikkala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Rahikkala more than expected).

Fields of papers citing papers by Elisa Rahikkala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Rahikkala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Rahikkala. The network helps show where Elisa Rahikkala may publish in the future.

Co-authorship network of co-authors of Elisa Rahikkala

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Rahikkala. A scholar is included among the top collaborators of Elisa Rahikkala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Rahikkala. Elisa Rahikkala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 0
5 0
6 4
7 0
8 3
9 0
10 3
11 1
12 1
13 9
14 3
15 7
16 20
17 5
18 56
19 2
20 14

About Elisa Rahikkala

Elisa Rahikkala is a scholar working on Clinical Biochemistry, Genetics and Developmental Biology, having authored 38 papers that have together received 269 indexed citations. Recurring topics across this work include Genomics and Rare Diseases (9 papers), Genetics and Neurodevelopmental Disorders (7 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Clinical Biochemistry (61 citations), Biochemistry (31 citations) and Genetics (81 citations). Elisa Rahikkala has collaborated with scholars based in Finland, Netherlands and United States. Frequent co-authors include Jukka S. Moilanen, Johanna Uusimaa, Päivi Vieira, Reetta Hinttala, Päivi Myllynen, Anne‐Dorte Sperfeld, Larissa Arning, Jörg T. Epplen, Corinna Hendrich and Albert C. Ludolph. Their work appears in journals such as Blood, International Journal of Cancer and Movement Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026